» Articles » PMID: 28574793

Automated Cell Culture Systems and Their Applications to Human Pluripotent Stem Cell Studies

Overview
Journal SLAS Technol
Publisher Sage Publications
Specialty Pathology
Date 2017 Jun 3
PMID 28574793
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Pluripotent stem cells are an extremely powerful tool in modeling human diseases and hold much promise for personalized regenerative or cell replacement therapies. There is an increasing need for reproducible large-scale stem cell and differentiated progeny production, with minimal variation, rendering manual approaches impracticable. Here, we provide an overview of systems currently available for automated stem cell culture, and undertake a review of their capacities, capabilities, and relative limitations. With the merging of modern technology and stem cell biology, an increased demand and implementation of automated platforms for stem cell studies is anticipated.

Citing Articles

Synergistic potential of stem cells and microfluidics in regenerative medicine.

Rajalekshmi R, Agrawal D Mol Cell Biochem. 2024; 480(3):1481-1493.

PMID: 39285093 PMC: 11842489. DOI: 10.1007/s11010-024-05108-8.


Challenges in validation of combination treatment strategies for CRC using patient-derived organoids.

Benboubker V, Ramzy G, Jacobs S, Nowak-Sliwinska P J Exp Clin Cancer Res. 2024; 43(1):259.

PMID: 39261955 PMC: 11389238. DOI: 10.1186/s13046-024-03173-x.


Automated human induced pluripotent stem cell culture and sample preparation for 3D live-cell microscopy.

Gregor B, Coston M, Adams E, Arakaki J, Borensztejn A, Do T Nat Protoc. 2023; 19(2):565-594.

PMID: 38087082 DOI: 10.1038/s41596-023-00912-w.


A clinically relevant large-scale biomanufacturing workflow to produce natural killer cells and natural killer cell-derived extracellular vesicles for cancer immunotherapy.

St-Denis-Bissonnette F, Cummings S, Qiu S, Stalker A, Muradia G, Mehic J J Extracell Vesicles. 2023; 12(12):e12387.

PMID: 38054534 PMC: 10698709. DOI: 10.1002/jev2.12387.


Natural Killer Cell-Derived Extracellular Vesicles as a Promising Immunotherapeutic Strategy for Cancer: A Systematic Review.

Chan A, Cheah J, Lokanathan Y, Ng M, Law J Int J Mol Sci. 2023; 24(4).

PMID: 36835438 PMC: 9964266. DOI: 10.3390/ijms24044026.